Levy Adam Scott (CIK 0001693134)

Latest company ownership

VRDN - Viridian Therapeutics, Inc.\DE
Role: Chief Business Officer
Shares held
13,040
Last filed at
Aug 22, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q2 2025Q4
Shares held
6,613
Last filed at
Nov 13, 2025
Confidence Score
3.6
2025Q4
Confidence Score History
2023Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 11, 2025 Nov 13, 2025 Mineralys Therapeutics, Inc. CFO Sell 16.3 -119,524 -86.04% ✗ $5.4M
Oct 13, 2025 Oct 15, 2025 Mineralys Therapeutics, Inc. CFO Sell 26.3 -10,758 -8.43% ✓ $452K
Jul 28, 2025 Jul 30, 2025 Mineralys Therapeutics, Inc. CFO Sell 17.5 -73,678 -35.66% ✗ $1.1M
Jul 11, 2025 Jul 15, 2025 Mineralys Therapeutics, Inc. CFO Sell 37.5 -10,758 -4.95% ✓ $155.5K
Apr 11, 2025 Apr 15, 2025 Mineralys Therapeutics, Inc. CFO Sell 37.5 -10,757 -4.76% ✓ $129.7K
Jan 13, 2025 Jan 15, 2025 Mineralys Therapeutics, Inc. CFO Sell 37.5 -10,757 -4.54% ✓ $97.9K
Oct 11, 2024 Oct 15, 2024 Mineralys Therapeutics, Inc. CFO Sell 37.5 -10,757 -4.34% ✓ $146K
Jul 11, 2024 Jul 12, 2024 Mineralys Therapeutics, Inc. CFO Sell 37.5 -10,757 -4.16% ✓ $141.4K
Jun 11, 2024 Jun 13, 2024 Mineralys Therapeutics, Inc. CFO Sell 5.0 -96,815 -27.48% ✓ $1.3M
Feb 14, 2023 Feb 16, 2023 Mineralys Therapeutics, Inc. CFO Buy 82.5 +6,250 1.81% ✗ $100K
Feb 13, 2018 Feb 13, 2018 Viridian Therapeutics, Inc.\DE Chief Business Officer Buy 91.3 +9,090 626.90% ✗ $50K
Jun 22, 2017 Jun 23, 2017 Viridian Therapeutics, Inc.\DE Chief Business Officer Buy 90.0 +200 100.00% ✗ $1.5K